Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor

Anton Arkhipov1, Yibing Shan1, Eric T Kim1

  • 1D. E. Shaw Research, New York, New York, United States of America.

Insights

Epidermal growth factor receptor (EGFR) negative cooperativity, crucial for cancer signaling, may stem from asymmetrical membrane interactions. Simulations reveal EGFR dimers interacting unevenly with cell membranes, impacting ligand binding.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Epidermal growth factor receptor (EGFR) signaling regulates vital cell functions like proliferation and differentiation.
  • Aberrant EGFR signaling is a hallmark of various human cancers.
  • EGFR activation involves ligand binding, dimerization, and subsequent intracellular signaling cascades.

Purpose of the Study:

  • To elucidate the structural basis of negative cooperativity in epidermal growth factor receptor (EGFR) ligand binding.
  • To investigate the role of membrane interactions in EGFR negative cooperativity.
  • To understand how ligand concentration affects EGFR-mediated signaling.

Main Methods:

  • Molecular dynamics simulations were employed to study EGFR dimer behavior.
  • Simulations focused on the extracellular domains of EGFR in interaction with a membrane environment.
  • Analysis included examination of ligand-binding site interactions and membrane contacts.

Main Results:

  • Molecular dynamics simulations suggest asymmetrical membrane interactions contribute to EGFR negative cooperativity.
  • EGFR dimers were observed to adopt orientations on the membrane favoring contact with one ligand-binding site over the other.
  • These asymmetrical interactions persisted even when EGFR was glycosylated, mimicking in vivo conditions.

Conclusions:

  • Asymmetrical interactions between EGFR dimers and the cell membrane are a likely structural origin of negative cooperativity in ligand binding.
  • This finding provides a novel perspective on the regulation of EGFR signaling.
  • Understanding this mechanism could offer new avenues for therapeutic interventions in EGFR-driven cancers.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.0K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
4.8K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.3K
Spare Receptors01:30

Spare Receptors

Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
4.9K